Vaccines developed by the pharmaceutical industry are transforming the lives of millions of people, every day. Find out how.
Vaccines developed by the pharmaceutical industry save lives, prevent diseases, benefit our economy and support the NHS.
The EU and the UK have reached an agreement on their future trading relationship beyond the end of the transition period.
ABPI has published the latest information on ‘transfers of value’ made to healthcare organisations and healthcare professionals by pharmaceutical companies. Find out more.
The UK has been leading the rest of Europe in early-stage clinical research according to new data published by the ABPI in its second annual report on the state of clinical trials in the UK.
The ABPI is calling for the research community to work with Government, funders, and the public to tackle issues around diversity and inclusion in research. This is essential, says ABPI President Haseeb Ahmad.
The COVID-19 pandemic is an unprecedented situation that is constantly changing. To help you understand how the pharmaceutical industry is responding, we answer your questions.
Our members are working 24/7 to get medicines to patients during the coronavirus pandemic.
Bringing together the most up-to-date information from the UK Government.
The Government has confirmed that COVID-19 testing capacity will increase.
As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19.
12 January 2021
The Government has laid a statement in Parliament updating on the Independent Medicines and Medical Devices Safety Review by Baroness Cumberlege.
11 January 2021
Tens of millions of people will be immunised by the spring at over 2,700 vaccination sites across the UK, according to the government's vaccines delivery plan.
09 January 2021
The Department of Health and Social Care has published the UK Rare Diseases Framework today, a national vision of how the UK will improve the lives of those living with rare diseases.
30 December 2020
The Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use.
11 November 2020
ABPI Chief Executive talks about the importance of vaccines, as ABPI launches its new campaign, #ValuingVaccines.
02 November 2020
The ABPI partnered with Reform on an event on the NICE Methods Review, titled 'A Global Science Superpower: The Future of Medicines Valuation.